Dalton’s contract services are complementary to Lonza’s value proposition in chemical custom manufacturing. With proximity to key customers in the North American pharmaceutical market they add desired geographic capability diversification to Lonza’s existing facilities network that ranges from kg-lab to large scale manufacturing capabilities (ISO, cGMP) in Visp, Switzerland and Nansha, China. Dalton’s offering includes contract chemistry research, contract analytical services and chemical synthesis up to cGMP Kilogram-scale as well as small scale fill-finish activities at their site in Toronto, Canada.

The alliance will enable seamless transition of custom small molecule projects from Dalton’s kg-lab scale through to Lonza’s clinical and commercial manufacturing scale. Our joint customers will benefit from aligned interfaces and tech transfer efficiency gains, hence save valuable time and cost.

Dalton was identified as competent innovator and qualified as Lonza-trusted partner following a diligent selection and auditing process.